Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New Tool for Monitoring Molecular Response in Patients With Chronic Myeloid Leukemia.
Badar T, Luthra R, Kantarjian H, Jabbour E, Borthakur G, Garcia-Manero G, Huang X, Singh R, Alvarez B, Austermiller B, Morrison TB, Patel KP, Cortes J. Badar T, et al. Appl Immunohistochem Mol Morphol. 2019 Jan;27(1):33-39. doi: 10.1097/PAI.0000000000000526. Appl Immunohistochem Mol Morphol. 2019. PMID: 28682832
The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms.
Gurney M, Chekkaf I, Baranwal A, Basmaci R, Katamesh B, Greipp P, Foran JM, Badar T, Mangaonkar AA, Begna KH, Gangat N, Patnaik MM, Litzow MR, Shah MV, Viswanatha DS, He R, Alkhateeb HB, Al-Kali A. Gurney M, et al. Among authors: badar t. Br J Haematol. 2023 Jul;202(2):279-283. doi: 10.1111/bjh.18850. Epub 2023 May 5. Br J Haematol. 2023. PMID: 37144345
Patients with telomere biology disorders show context specific somatic mosaic states with high frequency of U2AF1 variants.
Ferrer A, Lasho T, Fernandez JA, Steinauer NP, Simon RA, Finke CM, Carmona EM, Wylam ME, Ongie LJ, Burnap BN, Arana Yi C, Sproat LZ, Foran J, Badar T, Mangaonkar AA, Patnaik MM. Ferrer A, et al. Among authors: badar t. Am J Hematol. 2023 Dec;98(12):E357-E359. doi: 10.1002/ajh.27086. Epub 2023 Sep 4. Am J Hematol. 2023. PMID: 37665761
Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience.
Katamesh B, Nanaa A, He R, Viswanatha D, Nguyen P, Greipp P, Bessonen K, Gangat N, Begna K, Mangaonkar A, Patnaik M, Hogan WJ, Tefferi A, Litzow M, Shah MV, Yi CA, Foran J, Badar T, Alkhateeb HB, Al-Kali A. Katamesh B, et al. Among authors: badar t. Blood Adv. 2023 Apr 25;7(8):1351-1355. doi: 10.1182/bloodadvances.2022007937. Blood Adv. 2023. PMID: 36477202 Free PMC article. No abstract available.
Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blastphase myeloproliferative neoplasm.
Gangat N, Ilyas R, McCullough K, Begna KH, Al-Kali A, Patnaik MM, Litzow MR, Hogan WJ, Mangaonkar A, Alkhateeb H, Shah MV, Elliott MA, Foran JM, Badar T, Palmer JM, Hanson CA, Pardanani A, Tefferi A. Gangat N, et al. Among authors: badar t. Haematologica. 2023 May 1;108(5):1423-1428. doi: 10.3324/haematol.2022.282019. Haematologica. 2023. PMID: 36519330 Free PMC article. No abstract available.
91 results